Procuring Personalized Medicine Patents In US Vs. Europe
ثبت نشده
چکیده
Law360, New York (July 20, 2015, 9:56 AM ET) -Personalized medicine has been interchangeably called precision, tailored, targeted or genomic medicine. Broadly speaking, personalized medicine is individualized medicine that customizes medical treatment to a patient’s genetic characteristics, previous treatment history, lifestyle, environment and/or preferences. Simply put, it provides the right patient with the right drug, at the right dose, at the right time.
منابع مشابه
Role of personalized medicine in cardiovascular disease: A narrative review
Cardiovascular diseases are the leading cause of mortality each year. Both environmental and genetic risk factors significantly influence the incidence and progression of these diseases. In recent decades, with the development of genetics and genome-determining tools, different genes have been found associated with numerous diseases. Determining these genes helps us to suggest a more effective ...
متن کاملStem cell patenting in Europe - the twilight zone
Controversy often follows when patents are obtained in a pioneering area of technology. Patent filing activity in the field of regenerative medicine and in relation to stem cells in particular has not escaped opprobrium, although it is instructive to compare the nature of the debates that are taking place over the patenting of stem cells in the US and Europe. In the US, debate over the early pa...
متن کاملPersonalized Medicine in Europe
Scientific breakthroughs bring new opportunities to address disease and improve health outcomes for many communities in many parts of the world. Frequently, however, these advances come at an increased cost, and some communities do not benefit from the improvements in healthcare and health outcomes. Furthermore, manymedicines do not effectively treat some patients or are even harmful, as illust...
متن کاملBilski’s “Machine-or-Transformation” Test: Uncertain Prognosis for Diagnostic Methods and Personalized Medicine Patents
متن کامل
بررسی سیر تحول در ثبت اختراعات مرتبط با دی.اِن.اِی با تأکید بر رأی دیوان عالی آمریکا در قضیه انجمن پاتولوژی مولکولی علیه شرکت میریاد
Patentability of inventions related to biotechnology and genetics has been one of the most challenging issues in patent law. One of these challenges is whether patenting products in which natural components are used is correct? Can we put human genes in the ownership of certain individuals? In addition, exercising exclusive rights arising from patents will limit the access of people, in particu...
متن کامل